Glaukos Corporation (NYSE:GKOS) Q2 2024 Results Conference Call July 31, 2024 4:30 PM ET

Company Participants

Chris Lewis - VP, IR and Corporate Affairs
Tom Burns - Chairman and CEO
Joe Gilliam - President and COO
Alex Thurman - CFO

Conference Call Participants

Tom Stephan - Stifel
Larry Biegelsen - Wells Fargo
Ryan Zimmerman - BTIG
Harrison Parsons - Stephens
Margaret Kaczor - William Blair
Joanne Wuensch - Citibank
Rich Newitter - Truist Securities
Steve Lichtman - Oppenheimer
Anthony Petrone - Mizuho

Operator

Hello, and welcome to Glaukos Corporation's Second Quarter 2024 Financial Results Conference Call. Copies of the company's press release and quarterly summary document, both issued after the market closed today, are available at www.glaukos.com. All participants are currently in a listen only mode. Later, we will conduct a question and answer session [Operator Instructions]. To note, this call is being recorded and an archived replay will be available online in the Investor Relations section at www.glaukos.com. I will now turn the call over to Chris Lewis, Vice President of Investor Relations and Corporate Affairs.

Chris Lewis

Thank you, and good afternoon. Joining me today are Glaukos’ Chairman and CEO, Tom Burns; President and COO, Joe Gilliam; and CFO, Alex Thurman. Similar to prior quarters, the company has posted a document on its Investor Relations Web site under the Financials and Filings quarterly results section titled Quarterly Summary. This document is designed to provide the investment community with a summarized and easily accessible reference document that details the key facts associated with the quarter, the state of the company’s business objectives and strategies, and any forward statements or guidance we may make. This document is designed to be read by investors before the regularly scheduled quarterly conference call. As such, for this call, we will make brief prepared remarks and transition into a question-and-answer session. To ensure ample time and opportunity to address everyone’s questions, we request that you limit yourself to one question and one follow-up. If you still have additional questions, you may get back into the queue. Please note that all statements other than statements of historical facts made on this call that address activities, events or developments we expect, believe or anticipate, will or may occur in the future are forward-looking statements. These include statements about our plans, objectives, strategies and prospects regarding, among other things, our sales, products, pipeline technologies and clinical trials, US and international commercialization, market development efforts, the efficacy of our current and future products, competitive market position, regulatory strategies and reimbursement for our products, financial condition and results of operations, as well as the expected impact of general macroeconomic conditions, including foreign currency fluctuations on our business and operations.